Tech Company Financing Transactions
XtalPi Funding Round
On 10/25/2018, XtalPi received $46 million in Series B funding from China Life Insurance, SIG China and Yael Capital.
Transaction Overview
Company Name
Announced On
10/25/2018
Transaction Type
Venture Equity
Amount
$46,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds for continuous market growth and expansion of the application of its technology into new areas of pharmaceutical research.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
245 Main St. 11th Floor
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Undisclosed
Website
Email Address
Overview
XtalPi is a pharmaceutical technology company that is reinventing the industry's approach to drug research and development with its Intelligent Digital Drug Discovery and Development (ID4) platform.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Wen Shuhao
Chief Executive Officer
Ma Jian
Co-Founder
Lai Lipeng
Browse more venture capital transactions:
Prev: 10/25/2018: AssuriCare venture capital transaction
Next: 10/25/2018: Wahed venture capital transaction
Share this article
Where The Data Comes From
We do our best to document funding rounds that are announced publicly. VC investment data records on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs